Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 4
1(25.0%)
Phase 3
1(25.0%)
4Total
N/A(2)
Phase 4(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07543562Phase 3Recruiting

Selenium Intervention Registry Randomized Trial in Heart Failure

Role: collaborator

NCT07273409Not ApplicableRecruiting

Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not

Role: collaborator

NCT07236944Phase 4Recruiting

Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care

Role: collaborator

NCT02999412Not ApplicableCompleted

Medication Reviews Bridging Healthcare: a Cluster-randomised Crossover Trial

Role: collaborator

All 4 trials loaded